Altered Mental Status After an Unknown Ingestion

Learning objectives#

• Stabilize an adolescent with altered mental status before seeking a precise toxicologic label.
• Use vital signs, pupils, skin, secretions, temperature, neuromuscular findings, bowel and bladder clues, and response over time to build a toxidrome-based differential.
• Obtain collateral history without delaying care and without treating a friend, caregiver, or screening assay as a perfect historian.
• Choose decision-linked tests while explaining why a routine urine drug screen cannot exclude or quantify many ingestions.
• Coordinate serial monitoring, antidote decisions, mental-health assessment, and medical disposition with a poison center and emergency or critical-care team.

Initial presentation#

A 17-year-old student is found slumped on a bench in a community recreation center shortly after an evening program. A friend says the student had seemed anxious after receiving several messages, then disappeared into a restroom for about twenty minutes. When they returned, their speech was slow and they could not walk steadily. No one saw a fall, seizure, or ingestion. The friend says only that "there may have been pills" and is afraid of getting the group in trouble.

Emergency medical staff find the student difficult to arouse. Respirations are shallow at 7 per minute, oxygen saturation is 88 percent on ambient air, pulse is 112 per minute, blood pressure is 104/62 mm Hg, and temperature is 36.4 degrees Celsius. The pupils are small but reactive. Skin is neither hot and dry nor markedly sweaty. There is no obvious trauma, vomit, unusual odor, transdermal patch, or container nearby. Point-of-care glucose is within the device's normal range.

Airway positioning, suction readiness, and assisted ventilation begin immediately. So do oxygen, continuous monitoring, vascular access, and repeat examination. Because respiratory depression with small pupils raises an opioid effect, the team gives naloxone according to the emergency protocol while continuing ventilatory support. Breathing improves and the student opens their eyes, but they remain confused, intermittently somnolent, and unable to give a reliable history. The response supports opioid physiology without identifying a particular agent or excluding a co-ingestion.

At the emergency department, the student localizes pain and speaks a few unrelated words. There is no focal weakness. The neck is supple. Lungs are clear after assisted ventilation, heart rhythm is regular and fast, abdomen is soft, bowel sounds are present, and the bladder is not distended. There is no clonus, marked rigidity, or tremor. There is no flushing, heavy sweating, or excessive secretions. The emergency team asks a poison specialist to join the reasoning early rather than waiting for a laboratory label.

Problem representation#

This is an adolescent with abrupt depressed consciousness and dangerous hypoventilation after a possible but unconfirmed ingestion. Normal bedside glucose and partial improvement after naloxone make hypoglycemia less likely and an opioid effect more likely, but persistent confusion and tachycardia leave a mixed ingestion, another sedative, a postictal state, trauma, infection, or metabolic disease open.

The organizing problem is toxic or metabolic altered mental status with recurrent respiratory risk and an unreliable timeline. It is not "opioid overdose confirmed." The exact substance may remain unknown during the period when airway, ventilation, and circulation decisions must be made. Temperature, arrhythmia, seizure, and self-harm decisions fall in the same period.

The case has two parallel safety questions. The medical question is whether a delayed or recurrent toxic effect can cause respiratory, cardiac, hepatic, neurologic, or metabolic deterioration. The behavioral-health question is whether the ingestion was intentional and whether the student can be kept safe. The latter cannot be answered fully while the student is intoxicated, but immediate observation and means safety cannot wait.

Prioritized differential#

1. Opioid effect, possibly with another agent#

Reasoning for: Slow shallow breathing, depressed consciousness, small pupils, and improved ventilation after naloxone fit an opioid toxidrome. The AHA identifies respiratory failure as the central preventable pathway in severe opioid poisoning, and CDC guidance notes that naloxone can restore breathing when opioids are responsible.

Reasoning against or still uncertain: Pupils are reactive rather than fixed, tachycardia is nonspecific, and confusion persists after ventilation improves. Naloxone response does not reveal the agent, formulation, or route. It does not reveal amount, timing, or intent. A long-acting drug, recurrent effect, hypoxic injury, or co-ingestion remains possible.

2. Sedative-hypnotic or mixed central nervous system depressant ingestion#

Sedatives, alcohols, some antihistamines, and several prescribed medicines can produce somnolence and loss of airway reflexes. Mixed use can deepen respiratory depression and make a textbook toxidrome disappear. An antidote that reverses one component may leave another component active. A benzodiazepine antagonist is not used reflexively in an unknown ingestion because seizure, withdrawal, and dysrhythmia risks depend on the patient and co-ingestants.

3. Anticholinergic, sympathomimetic, or serotonergic toxicity#

These syndromes can cause agitation or confusion, tachycardia, temperature change, pupil change, and seizures. Hot dry skin, urinary retention, absent bowel sounds, and marked dilation would support an anticholinergic pattern. Profuse sweating, severe agitation, hypertension, and hyperthermia would favor a sympathomimetic pattern. Clonus, hyperreflexia, autonomic instability, and compatible medicines would raise serotonin toxicity. None is established now, but mixed syndromes can evolve.

4. Time-sensitive agents with few early symptoms#

Some ingestions initially produce limited findings while later causing hepatic injury, metabolic acidosis, dysrhythmia, shock, or neurologic decline. Acetaminophen and salicylate concentrations are therefore considered even when the bedside pattern points elsewhere. The team also looks for sodium-channel effects on the electrocardiogram and uses history, acid-base status, osmolality, kidney function, and clinical course to decide whether toxic alcohol or another metabolic poison needs targeted testing.

5. Non-toxicologic altered mental status#

Seizure with a postictal period, head injury, and central nervous system infection remain alternatives. So do hypoxia, hypoglycemia, and electrolyte disturbance. So do hepatic or renal disease, stroke, pregnancy-related disease, and primary psychiatric illness. A psychiatric diagnosis must not be used to explain impaired consciousness before medical threats are assessed. The absence of fever, meningismus, trauma signs, and focal deficits lowers some branches but does not close them if recovery stalls.

6. Deliberate self-harm, accidental use, or substance-use disorder#

Intent is not a toxidrome. The same physiology can follow self-harm, recreational use, or an attempt to relieve distress. It can follow a medication error, coercion, or an unknown product. The student needs private assessment after sufficient recovery, plus collateral and safeguarding now. Substance-use disorder is not inferred from one event.

Focused history and examination#

Collateral gathered during stabilization#

One clinician coordinates history while the resuscitation team continues care. Emergency staff ask where and when the student was last seen well, what changed first, whether there was a fall or seizure, whether anyone administered naloxone or another treatment, and whether a container, photograph, receipt, message, or medication list can identify a product. Each friend is interviewed briefly and separately in a nonpunitive tone to reduce group editing and fear.

With attention to local consent and privacy rules, the team contacts the student's aunt and legal guardian. She reports no chronic medical disease but notes recent insomnia and conflict at school. The home contains several prescription and nonprescription medicines used by different family members; she cannot immediately confirm whether anything is missing. Pharmacy records and the primary-care list are checked for legitimate prescriptions, interactions, and formulations that could cause delayed effects. The poison-center record captures what is known, what is uncertain, and when each fact was learned.

The history also covers alcohol or drug use, patches or liquids, herbal or imported products, possible carbon monoxide contact, hobby chemicals, pregnancy possibility, diabetes, seizures, head injury, eating disorder, and recent suicidal thoughts. Questions avoid naming long substance lists in front of peers.

Serial toxidrome examination#

The examination is repeated because trajectory is diagnostic. It records respiratory rate and depth, oxygenation and ventilation, heart rate and rhythm, blood pressure, temperature, mental status, pupil size and reactivity, oral moisture and secretions, skin temperature and moisture, bowel sounds, bladder fullness, muscle tone, reflexes, clonus, rigidity, tremor, trauma signs, and focal neurologic findings.

No single sign is absolute. Hypoxia alters consciousness, and opioids do not always produce pinpoint pupils. Skin moisture, bowel and bladder function, and neuromuscular findings help separate patterns. Sedation can hide trauma, so the team reassesses after ventilation improves.

Diagnostic strategy#

Immediate decision-linked studies#

Bedside glucose is repeated if the clinical state changes. Continuous oxygenation, cardiac rhythm, respiratory observation, and temperature monitoring begin early; capnography can help detect inadequate ventilation where available. A twelve-lead electrocardiogram is obtained and repeated if symptoms, rhythm, or intervals change. QRS widening, marked repolarization abnormality, conduction block, or ventricular dysrhythmia would trigger agent-directed toxicology and resuscitation pathways.

Initial blood testing assesses electrolytes, kidney function, and glucose. It assesses liver tests, acid-base status, and lactate. Acetaminophen and salicylate concentrations are ordered because early findings may be limited and timely treatment matters. Ethanol testing can clarify one contributor but does not make a patient with severe depression safe. A pregnancy test is offered when biologically relevant because it affects imaging, medication, and safeguarding decisions, while emergency stabilization proceeds regardless of the result.

Concentration timing matters. A value drawn too early or without a reliable ingestion time may require repetition and poison-center interpretation. A treatment graph validated for a known single acute acetaminophen ingestion cannot be forced onto an unknown or staggered timeline.

What the urine screen can and cannot answer#

The hospital's routine immunoassay panel is not a universal toxicology test. The ACMT explains that many opioid assays primarily target morphine-like compounds and require separate assays for several synthetic or semisynthetic opioids. A negative result can therefore miss a clinically important opioid. A positive result indicates that a tested analyte or cross-reacting compound is present above a cutoff; it does not prove current impairment, amount, timing, source, or intent.

Cross-reactivity can produce false positives. Confirmatory chromatography may be more specific but often returns too late for resuscitation. The clinician checks the local assay menu before interpreting a result, and no result overrides physiology.

Selective imaging and invasive testing#

Head imaging is reserved for trauma, focal findings, anticoagulation, unexplained persistent depression, or another intracranial concern. Lumbar puncture and antimicrobial evaluation become relevant with fever, meningismus, immune compromise, or persistent unexplained encephalopathy. A broad computed-tomography survey is not a poison screen. Gastric emptying procedures are not routine and can cause harm.

Progressive results and interpretation#

The first electrocardiogram shows sinus tachycardia without clinically important QRS or repolarization abnormality. Acid-base testing reflects hypoventilation but begins to correct with respiratory support. Electrolytes, kidney function, glucose, and initial liver tests do not reveal an alternative cause. Ethanol and salicylate testing are negative. Acetaminophen is detectable, but the time and pattern of ingestion remain unknown, so the number cannot be plotted safely as though a reliable single time were known.

The routine urine opiate immunoassay is negative. The team explicitly documents that this does not contradict the respiratory toxidrome or the naloxone response. A separate broad screen would still not replace bedside management. The result prevents false certainty rather than supplying it.

About an hour later, the student's respiratory rate slows again and arousal decreases. Assisted ventilation resumes and protocol-directed naloxone again improves breathing. Recurrence suggests that the opioid effect outlasts the initial antagonist response or that another depressant remains active. It raises the required level and duration of monitoring; it does not invite progressively larger empiric treatment without expert reassessment.

The poison specialist recommends beginning acetaminophen antidotal treatment because the concentration is detectable and the timing cannot yet be trusted, while repeating the concentration and liver assessment under the local pathway. Exact dosing is intentionally omitted. Early antidotal treatment has a different risk-benefit balance from waiting for preventable hepatic injury, and continuation or stopping depends on serial criteria reviewed with toxicology.

Once the student can converse coherently, they say they took tablets from an unlabelled container after an intense online conflict. They remember that some were pain medicines but do not know all the products. They are unsure whether they expected to die and become tearful when asked about going home. This history supports a mixed and potentially deliberate ingestion but still does not prove every substance. The guardian later identifies missing prescription pain medicine and a nonprescription analgesic package, which is consistent with the clinical branches without making collateral infallible.

Management plan#

Stabilization and supportive care#

Airway protection and effective ventilation remain the first treatment. Oxygen alone is insufficient when ventilation is inadequate. The team prepares for a definitive airway if the student cannot maintain protective reflexes, ventilation, or oxygenation despite immediate support. Aspiration precautions, positioning, and suction proceed in parallel. So do temperature control, cardiac monitoring, vascular access, and correction of glucose or electrolyte emergencies.

Naloxone is used to restore adequate breathing when opioid poisoning is suspected. The target is ventilation and airway safety, not necessarily full wakefulness. Recurrence requires continued observation and may require repeated or continuous antagonist support under the emergency and toxicology protocol. Agitation or withdrawal after reversal is managed with de-escalation, injury prevention, and specialist guidance rather than punitive restraint.

Activated charcoal is not automatic. Altered consciousness and an unprotected airway create aspiration risk, and benefit varies by substance and timing. It is considered only when a specific, potentially adsorbable ingestion, a meaningful time window, and adequate airway protection make benefit plausible after poison-center discussion. Induced vomiting and routine gastric lavage are avoided.

Agent-directed and complication-directed care#

The team follows specialist pathways for evolving conduction abnormality, seizure, or hyperthermia. The same applies to severe agitation, shock, acidosis, or organ injury. Antidotes are selected for a supported syndrome or identifiable agent with contraindications reviewed. Critical poisoning may require uncommon treatments in addition to standard resuscitation.

For the detectable acetaminophen result with an uncertain timeline, antidotal therapy follows the specialist pathway. So does serial liver, coagulation, kidney, acid-base, and concentration assessment. Treatment is not delayed for confirmatory history. It is also not continued or stopped merely because the student looks awake; the organ-risk criteria are separate from mental status.

The team avoids reflex use of a benzodiazepine antagonist in this unknown mixed ingestion because tolerance, seizure risk, and pro-convulsant co-ingestants have not been excluded. Similarly, a normal early electrocardiogram does not justify discharge when respiratory depression has recurred.

Behavioral safety after medical stabilization#

The student remains under direct, developmentally appropriate observation in a safe environment. Potentially dangerous items are removed according to policy without humiliating searches or unnecessary law-enforcement involvement. Once sufficiently alert, the student is interviewed privately about intent, current thoughts, prior self-harm, access to medicines or firearms, coercion, substance use, abuse, protective relationships, and whether the guardian is safe to involve.

A positive suicide screen leads to a trained brief safety assessment and, when indicated, a full mental-health evaluation. A promise not to repeat the act is not a disposition plan. Medical admission does not postpone behavioral safety; psychiatric transfer does not occur until ongoing respiratory and organ risks can be managed safely at the receiving level of care.

Escalation, referral, and safety net#

Critical-care escalation is required for inability to protect the airway, recurrent or persistent hypoventilation, rising carbon dioxide, hypoxemia, repeated antidote need, seizures, severe agitation with hyperthermia or acidosis, significant conduction abnormality or dysrhythmia, shock, worsening metabolic acidosis, evolving organ injury, or a need for uncommon antidotal or extracorporeal support. Transfer to a center with medical toxicology, pediatric critical care, or advanced resuscitation capability is arranged early when local resources cannot meet those needs.

Emergency neurologic or infectious evaluation rises with focal deficits, persistent coma despite corrected ventilation and metabolic abnormalities, fever, meningismus, signs of head injury, or a witnessed seizure without expected recovery. The working label of poisoning must remain revisable.

The student cannot be discharged while recurrent respiratory depression, an uncertain long-acting effect, rising laboratory risk, an incomplete observation interval, inability to participate in safety assessment, current suicidal intent, unsafe supervision, or access to lethal means remains unresolved. A low-risk laboratory panel never overrides those findings.

In the United States, a person who is unconscious, seizing, not breathing normally, or in immediate danger needs emergency services. Poison Help at 1-800-222-1222 connects callers and clinicians with regional specialists around the clock. Other countries use local systems. Do not induce vomiting or rely on online calculations.

Communication, shared decisions, and equity#

The team uses neutral language: "Your breathing became dangerously slow, and we are treating that while we work out what may have contributed." Terms such as addict, drug seeker, manipulative, or attention-seeking do not belong in the handoff. One event does not establish a substance-use disorder, and uncertainty about intent is recorded as uncertainty rather than dishonesty.

Friends are told that accurate information can save a life and that the medical team is focused on safety, while confidentiality limits are preserved. The guardian receives enough information to support immediate care and means safety under applicable law. The student is told before private questions that imminent safety, abuse, or mandatory-reporting concerns may require limited disclosure. If the guardian may be a source of danger, child-protection and social-work pathways replace automatic family disclosure.

Professional interpreters are used when preferred. Care accommodates disability, neurodivergence, and gender identity. It accommodates literacy, culture, and trauma. Fear of punishment, school consequences, immigration effects, rejection, or law enforcement may inhibit disclosure. A nonpunitive approach improves accuracy.

Cost and geography affect antidote availability, transfer, psychiatric placement, and follow-up. The case manager confirms transport, assistance, pharmacy access, a safe phone, and a backup crisis route. Shared decisions cannot make an unsafe discharge equivalent to monitored care.

Follow-up and contingencies#

Because respiratory depression recurs and the ingested products and timing remain uncertain, the student is admitted to a monitored pediatric critical-care setting. The emergency clinician hands off last-known-well time, serial vital and neurologic findings, ventilation support, naloxone response and recurrence, electrocardiograms, laboratory timing, poison-center recommendations, pending tests, collateral sources, and immediate behavioral-safety status.

During admission, the team reassesses breathing, consciousness, and temperature. It reassesses rhythm, acid-base status, organ function, and agent-specific markers until a specialist-supported clearance point. The poison center is called back when physiology changes and before stopping treatment based on serial criteria.

After stable cognition returns, a full suicide and mental-health assessment explores intent, ambivalence, and prior behavior. It explores depression, anxiety, and trauma. It explores impulsivity, substance use, and bullying. It explores online harm, family safety, and protective relationships. Current thoughts, a feasible plan, inability to collaborate, or an unsafe environment require emergency psychiatric care. Disposition is coordinated so neither the medical nor behavioral team assumes the other is managing the remaining risk.

Before any later home discharge, medicines and other dangerous items are removed or secured, a responsible adult can supervise, a written safety plan is completed, crisis and follow-up contacts are live, and early check-in is arranged. Naloxone education and access are offered when opioid risk is plausible, without treating that as a substitute for treatment. The plan connects the student to primary care, mental-health care, and age-appropriate substance-use services when indicated.

Follow-up corrects misinformation: a negative screen is not proof that nothing happened, and naloxone response is not proof of a specific drug. Confirmatory results are interpreted with laboratory and toxicology support for a defined purpose.

Reasoning traps and alternative pathways#

• Waiting for the name of the substance: Airway, ventilation, circulation, glucose, temperature, rhythm, and seizures are treated before certainty.
• Calling naloxone response a chemical identification: Response supports opioid physiology but does not identify the product or exclude a second agent.
• Believing a negative routine screen: Assay menus and cutoffs are narrow. Many opioids and other poisons require separate tests or are not rapidly measurable.
• Treating a positive screen as impairment or intent: Detection cannot establish dose, timing, clinical effect, source, or why the substance was taken.
• Using a textbook toxidrome too rigidly: Mixed ingestion, hypoxia, age, prescribed medicines, and time can blur classic patterns.
• Giving charcoal reflexively: Aspiration risk and uncertain benefit can outweigh value in an obtunded patient.
• Using psychiatric history to stop medical workup: Self-harm and organic illness can coexist; depressed consciousness is a medical emergency.
• Performing a definitive suicide interview too early: Immediate observation begins now, while reliable assessment waits for adequate cognition.
• Discharging after temporary arousal: Antidote effects can be shorter than the causative drug, and delayed organ injury can evolve after alertness returns.
• Punishing peers or caregivers for incomplete information: Fear worsens collateral quality. Ask specific, neutral questions as facts emerge.
• Failing to close the poison-center loop: Initial advice changes when breathing recurs, laboratory values evolve, or a product becomes known.

An alternate pathway with hot dry skin, dilated pupils, urinary retention, absent bowel sounds, and delirium would prioritize anticholinergic toxicity. Severe agitation, sweating, hypertension, and hyperthermia would raise a sympathomimetic syndrome. Clonus and hyperreflexia would redirect toward serotonin toxicity. A wide QRS or ventricular dysrhythmia would trigger a sodium-channel pathway. Persistent coma without a coherent toxic pattern would accelerate brain imaging, infectious evaluation, and other neurologic workup.

Evidence limits and what could change#

Unknown-ingestion care depends on physiology, serial observation, poison-center knowledge, and agent-specific evidence. Many antidote studies are observational. The AHA emphasizes consultation. Poison centers adapt advice to product, age, and timing, and to laboratory capability and rescue options.

Urine immunoassays are product-specific. Hospital panels differ, and detection windows do not equal impairment windows. Confirmation may improve specificity without reconstructing intent or timing.

The NIMH youth pathway and AAP clinical report support structured suicide assessment, but no score predicts behavior perfectly. Consent, confidentiality, and guardian access vary by jurisdiction. So do involuntary treatment, mandatory reporting, and transfer rules. The clinical team must use current local law and policy without delaying emergency protection.

The course described in this analysis assumes recurrent respiratory depression, a detectable time-sensitive analgesic, and later disclosure of deliberate tablet ingestion. A different response, electrocardiogram, or acid-base pattern could change every later decision. So could a different product, timeline, trauma finding, pregnancy status, or collateral account. This high-risk case has completed human review by Jasaman (Jasmin) Tojjar, MD, PhD.

Key points#

• Stabilize breathing, circulation, glucose, temperature, rhythm, and seizures before seeking a precise substance label.
• Toxidromes are evolving patterns, not single signs, and mixed ingestions may blur them.
• Naloxone response supports an opioid effect but does not identify the agent, amount, timing, intent, or co-ingestants.
• Routine urine drug screens are assay-limited and should never overrule the patient's physiology.
• Early poison-center coordination connects serial findings to antidote, monitoring, and transfer decisions.
• Medical and suicide-risk disposition are parallel duties; neither is complete until the patient can be safely received at the next level of care.